These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38383267)

  • 21. Rituximab alleviates pediatric systemic lupus erythematosus associated refractory immune thrombocytopenia: a case-based review.
    Mu F; Bai X; Lou Y; Luo P; Guo Q
    Immunol Res; 2024 Jun; 72(3):503-511. PubMed ID: 38279058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct antiglobulin (Coombs) test in systemic lupus erythematosus patients.
    Skare T; Picelli L; Dos Santos TAG; Nisihara R
    Clin Rheumatol; 2017 Sep; 36(9):2141-2144. PubMed ID: 28762061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients.
    Roussotte M; Gerfaud-Valentin M; Hot A; Audia S; Bonnotte B; Thibault T; Lobbes H; Le Guenno G; Goulabchand R; Cathebras P; Varron L; Dufour JF; Deroux A; Compain C; Baudet A; Karkowski L; Pérard L; Ebbo M; Lega JC; Sève P
    Rheumatology (Oxford); 2022 Aug; 61(9):3627-3639. PubMed ID: 34918048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus.
    Mestanza-Peralta M; Ariza-Ariza R; Cardiel MH; Alcocer-Varela J
    J Rheumatol; 1997 May; 24(5):867-70. PubMed ID: 9150074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
    Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
    Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study.
    Wu Q; Zhao MX; Huang XS; Lin CS; Xu Q
    Lupus; 2024 May; 33(6):608-614. PubMed ID: 38518059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort.
    Conti F; Ceccarelli F; Perricone C; Leccese I; Massaro L; Pacucci VA; Truglia S; Miranda F; Spinelli FR; Alessandri C; Valesini G
    Lupus; 2016 Jun; 25(7):719-26. PubMed ID: 26821965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
    Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
    Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
    Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antiphospholipid antibodies in patients with overt myocardial dysfunction in systemic lupus erythematosus. A case-control study.
    Gawalkar AA; Bahl A; Ahluwalia J; Sood A; Sharma A; Sharma S; Dhir V
    Lupus; 2020 Oct; 29(12):1503-1508. PubMed ID: 32752919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
    Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
    Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.
    Sebastiani GD; Prevete I; Piga M; Iuliano A; Bettio S; Bortoluzzi A; Coladonato L; Tani C; Spinelli FR; Fineschi I; Mathieu A
    Lupus; 2015 Oct; 24(12):1276-82. PubMed ID: 25979916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral Venous Sinus Thrombosis in Systemic Lupus Erythematosus.
    Darmawan G; Hamijoyo L; Oehadian A; Bandiara R; Amalia L
    Acta Med Indones; 2018 Oct; 50(4):343-345. PubMed ID: 30631001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study.
    Gimeno-Torres L; Carrión-Barberà I; Durán X; Villegas E; Monfort J; Salman-Monte TC
    Lupus; 2021 Nov; 30(13):2095-2101. PubMed ID: 34794346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.
    Altintas A; Ozel A; Okur N; Okur N; Cil T; Pasa S; Ayyildiz O
    J Thromb Thrombolysis; 2007 Oct; 24(2):163-8. PubMed ID: 17436144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia.
    Fabris F; Steffan A; Cordiano I; Borzini P; Luzzatto G; Randi ML; Girolami A
    Eur J Haematol; 1994 Oct; 53(4):232-6. PubMed ID: 7957808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.
    Brunner HI; Silverman ED; To T; Bombardier C; Feldman BM
    Arthritis Rheum; 2002 Feb; 46(2):436-44. PubMed ID: 11840446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE.
    Esteves GCX; Gormezano NWS; Pereira OL; Kern D; Silva CA; Pereira RMR; Kozu KT; Bonfá E; Aikawa NE
    Mod Rheumatol; 2018 Jul; 28(4):649-653. PubMed ID: 29067848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.